Tech
Eli Lilly's $2.875B Merida Bet: Doubling Down on Biotech in a Pricing Pressure Cooker
Eli Lilly acquires Merida Biosciences for up to $2.875B in cash, signaling aggressive M&A strategy amid drug pricing headwinds.
Marcus Rivera • August 31, 2026
Markets-and-Money
Aon's $17 Billion Acquisition: Market Reactions and Insights
Aon's acquisition of USI for $17 billion signals major shifts in the insurance brokerage market.
Sarah Chen • Aug 31
US Politics
Trump's Drug Pricing Policy: Implications for the Pharmaceutical Sector
Trump's upcoming drug pricing announcement could reshape pharmaceutical valuations and share prices significantly.
James McAllister • Aug 31
Defense
Mobix Labs Acquires Vision Aerial: A Strategic Move in the US Drone Market
Mobix Labs' acquisition of Vision Aerial positions it for substantial growth in the drone sector, projected at 93% in 20…
Marcus Rivera • Aug 31
Free Newsletter
Informed positions start with informed mornings.
Market-moving analysis and institutional-grade research, complimentary and delivered daily.
More Stories
Energy
Oil Prices Surge Amid US-Iran Tensions: Market Implications and Energy Sector Insights
Sarah Chen • Aug 31, 2026
Markets-and-Money
Aon's $17 Billion Acquisition of USI: A Game-Changer for the Insurance Sector
James McAllister • Aug 31, 2026
Critical Minerals
GFL Environmental's Sale Process: What Investors Need to Know
Marcus Rivera • Aug 30, 2026
Markets-and-Money
Fed Chair Warsh's Hawkish Stance: Implications for US Markets
James McAllister • Aug 30, 2026
